What Researchers Did
Researchers conducted an examiner-blinded, block-randomized, controlled, crossover study with 19 healthy subjects to investigate the effects of hyperbaric oxygen therapy (HBOT) on burn injury-induced secondary hyperalgesia.
What They Found
A single session of hyperbaric oxygen therapy (HBOT) significantly reduced secondary hyperalgesia areas (SHA) compared to control sessions, with a mean reduction of 18.8 cm² (95% CI: 10.5-27.0 cm²). This mitigating effect on burn injury-induced SHA was observed both acutely and long-lastingly, confirming central anti-inflammatory and neuroplasticity effects of HBOT.
What This Means for Canadian Patients
For Canadian patients experiencing pain conditions characterized by secondary hyperalgesia, such as certain types of neuropathic pain or chronic pain, hyperbaric oxygen therapy could potentially offer a novel therapeutic approach. If further research confirms these effects in clinical populations, HBOT might provide a non-pharmacological option to reduce pain sensitivity and improve quality of life.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A limitation of this study is its small sample size of 19 healthy subjects, which may not fully represent clinical populations experiencing chronic pain or hyperalgesia.